United States Renal Data System, Minneapolis Medical Research Foundation, 914 South 8th Street, Suite S4,100, Minneapolis, Minnesota 55404, USA.
BMC Nephrol. 2014 Feb 8;15:30. doi: 10.1186/1471-2369-15-30.
The choice of vascular access type is an important aspect of care for incident hemodialysis patients. However, data from the Centers for Medicare & Medicaid Services (CMS) Medical Evidence Report (form CMS-2728) identifying the first access for incident patients have not previously been validated. Medicare began requiring that vascular access type be reported on claims in July 2010. We aimed to determine the agreement between the reported vascular access at initiation from form CMS-2728 and from Medicare claims.
This retrospective study used a cohort of 9777 patients who initiated dialysis in the latter half of 2010 and were eligible for Medicare at the start of renal replacement therapy to compare the vascular access type reported on form CMS-2728 with the type reported on Medicare outpatient dialysis claims for the same patients. For each patient, the reported access from each data source was compiled; the percent agreement represented the percent of patients for whom the access was the same. Multivariate logistic analysis was performed to identify characteristics associated with the agreement of reported access.
The two data sources agreed for 94% of patients, with a Kappa statistic of 0.83, indicating an excellent level of agreement. Further, we found no evidence to suggest that agreement was associated with the patient characteristics of age, sex, race, or primary cause of renal failure.
These results suggest that vascular access data as reported on form CMS-2728 are valid and reliable for use in research studies.
血管通路类型的选择是新发生血液透析患者护理的一个重要方面。然而,来自医疗保险和医疗补助服务中心(CMS)医疗证据报告(CMS-2728 表)的数据以前并未对新发生患者的首次血管通路进行验证。自 2010 年 7 月起,医疗保险开始要求在索赔中报告血管通路类型。我们旨在确定 CMS-2728 表报告的起始血管通路与医疗保险索赔报告的血管通路之间的一致性。
本回顾性研究使用了 9777 例在 2010 年下半年开始透析且在开始肾脏替代治疗时符合医疗保险条件的患者队列,以比较 CMS-2728 表报告的血管通路类型与同一患者的医疗保险门诊透析索赔报告的类型。对于每位患者,从每个数据源报告的通路都进行了汇总;报告通路的百分比表示相同通路的患者比例。进行了多变量逻辑分析,以确定与报告通路一致的特征。
两种数据源在 94%的患者中一致,Kappa 统计量为 0.83,表明一致性水平很高。此外,我们没有发现证据表明一致性与患者的年龄、性别、种族或肾衰竭的主要原因等特征有关。
这些结果表明,CMS-2728 表报告的血管通路数据可用于研究,是有效且可靠的。